BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Pre-Clinical (World)
Glide Pharma Completes Successful Proof-Of-Concept Study With Novel Solid Dose Formulation Of Octreotide 7/22/2014
Addex Therapeutics (ADXN.SW) ADX71441 Positive Results In Preclinical Model Of Nicotine Addiction 7/10/2014
TRANSGENE (ENX:TNG) Announces Presentation Of Data On TG1050 Immunotherapy Against Chronic Hepatitis B And Provides Update On Its Joint Venture With Tasly Pharmaceutical In China 7/1/2014
BiOptix And Altermune Technologies Present At Drug Analysis 2014 6/27/2014
RedHill Biopharma Ltd. (RDHL) Announces Positive Preliminary Pre-Clinical Data With RHB-104 For The Treatment Of Type 1 Diabetes 6/26/2014
Apitope Progresses Graves' Disease Treatment 6/19/2014
Success In Kadimastem’s First Pre-Clinical Trial For Treatment Of Amyotrophic Lateral Sclerosis (ALS) 6/19/2014
Zealand Pharma  (ZEAL.CO) Presented New Data On Two Novel Peptide Therapeutics From Its Preclinical Diabetes Pipeline At The American Diabetes Association 74th Scientific Sessions 6/17/2014
Five Scientific Communications At The European Academy Of Allergy And Clinical Immunology Congress Further Support DBV Technologies's EPIT™ Disease Modifying Effect 6/11/2014
Cellectis And Accelera (Nerviano Medical Sciences (NervianoMS)) Sign An Agreement To Complete Preclinical Studies Of Cellectis’ Lead Product Candidate UCART19 6/5/2014
Galmed Pharmaceuticals Release: Recently Published Independent Research Supports The Importance Of Reverse Cholesterol Transport On NASH Pathogenesis 6/4/2014
Implandata Successfully Launched Pre-Clinical Studies For New To The World Implantable 24h Extraocular Sensor For Intraocular Pressure Measurement At Glaucoma Patients 6/3/2014
Theralase Technologies Inc. (TLT.V) Discovers Anti-Cancer Memory Response 6/2/2014
Novogen Limited (NVGN) Identifies Highly Active Drug Candidates Against Prostate Cancer 5/27/2014
Da Volterra Presents New Data Supporting DAV132 As A Promising Candidate To Protect The Intestinal Flora And Prevent Severe Clostridium Difficile Infections 5/12/2014
Apitope Initiates Preclinical Development Of Peptide Therapy, ATX-F8-117, To Treat Factor VIII Intolerance 5/7/2014
Albireo’s Lead Compound In Cholestatic Liver Diseases, A4250, Protects Against Bile Acid-Mediated Cholestatic Liver Injury In Mice 4/11/2014
ERYtech Pharma Picks Up A New Candidate For Its Tumor Starvation Pipeline 4/9/2014
Domainex Ltd Programme Shows Great Promise For The Treatment Of Inflammatory Diseases, Such As Chronic Obstructive Pulmonary Disease (COPD) 4/7/2014
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS - Toxicology Study Main Findings 4/1/2014
Patrys Limited (PAB.AX) PAT-LM1 Advancing To The Clinic 3/24/2014
Novagen, Inc. And CanTx Experimental Drug, Trx-1, Proves Effective In Vivo 3/18/2014
Kymab Announces Publication Of The Kymouse Technology In Nature Biotechnology 3/17/2014
Preclinical Results For Pluristem Therapeutics (PSTI)'s PLX-PAD Cells In Tendon Injury Presented At American Academy of Orthopaedic Surgeons' Annual Meeting 3/12/2014
BioLineRx Ltd. Announces Positive Preclinical Results For Novel Treatment For Chronic Myeloid Leukemia 2/12/2014
Cellectis Grants genOway An Exclusive Sublicense For Its Homologous Recombination Technology In The Field Of Genetically Modified Rodent Models 2/4/2014
GENFIT Corp. (ALGFT): Preclinical Data Support Anti-Cancer Effects Of GFT505 1/29/2014
Novozymes Biopharma Announces New Data Highlighting Potential For Monthly Drug Dosing 1/27/2014
NovoCure Ltd. Enrolls First Patient In Pilot Clinical Trial Of Novottf™ Therapy Plus Gemcitabine For First-Line Treatment Of Advanced Pancreatic Adenocarcinoma 1/24/2014
Clasado And University of Oxford Demonstrate Effect Of Prebiotics On Brain And Gut In Pre-Clinical Study 1/23/2014
NovoCure Ltd. Release: Data Published In Pancreatology Demonstrates Activity Of NovoTTF™ Therapy In Preclinical Models Of Pancreatic Cancer, Alone And In Combination With Chemotherapy 1/7/2014
Galapagos NV (GLPG.BR) Selects Pre-Clinical Candidate For Cystic Fibrosis 12/16/2013
Evotec AG (EVTG.F): Results Of Pre-Clinical Studies Lead To Reduction In Revenues, Nevertheless Profitable And More Than EURO 90 M Cash For 2013 Confirmed 12/13/2013
Evotec AG (EVTG.F) Receives Pre-Clinical Milestone As Part Of Its Discovery Alliance With Boehringer Ingelheim Corporation 12/10/2013
Neuroptis Biotech Announces The Preclinical Results For Its Dry Eye Product ML7 11/12/2013
AM-Pharma Holding BV Presents Positive Data From recAP Preclinical Study at American Society of Nephrology Meeting 11/8/2013
"New" Infectious Diseases: Clinical Tests on Innovative Themis Vaccine 11/7/2013
AIMM Therapeutics' Pre-Fusion RSV Antibodies Facilitate Improved Approach to Vaccine Development 11/4/2013
Ablynx (ABLYF) to Present Pre-clinical Proof-of-Concept Data on ALX-0761 at American College of Rheumatology 10/28/2013
S-TARget Achieves Clinical Proof of Concept for Allergy Vaccine SG100 in Asthmatic Non-Human Primates 10/10/2013
Medivir AB (MVIRb.F): MIV-247 Has Been Selected as a Candidate Drug and Enters Development for the Treatment of Neuropathic Pain 10/10/2013
Compugen Ltd. (CGEN) Drug Candidate Demonstrates High Effectiveness in Type I Diabetes Animal Model 10/9/2013
Addex Therapeutics (ADXN.SW) ADX71441 Dose Dependently Reduced PMP22 Expression Comparable to Baclofen in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease 10/3/2013
Zealand Pharma  (ZEAL.CO) Presents New Preclinical Data on its GLP-1-Gastrin Dual Agonist, Which Shows Potential as a Novel Approach for the Treatment and/or Prevention of Type 2 Diabetes 9/26/2013
Compugen Ltd. (CGEN) Target for Cancer Immunotherapy Shown to Affect Multiple Immune Cell Types Involved in Tumor Progression 9/17/2013
PRECOS Highlights Latest Advances in PDX Modelling for Oncology Drug Discovery to Increase Effectiveness of Drugs for Cancer Patients 9/13/2013
Karo Bio AB Receives Funding From the National MS Society to Develop ERbeta Agonists for Treatment of Progressive Multiple Sclerosis 9/12/2013
Alcobra (ADHD)'s Pre-Clinical Fragile X Study for MG01CI Shows Significant Positive Results 9/10/2013
Chronic Treatment With Addex Therapeutics (ADXN.SW) Dipraglurant Rescues Impairment of Long-Term Synaptic Plasticity in a Validated Preclinical Model of Primary Generalized Torsion Dystonia 1 9/4/2013
Coffee and Tea May Contribute to a Healthy Liver, Duke-NUS Graduate Medical School Study 8/16/2013
Rib-X Pharmaceuticals, Inc. Presents Data Demonstrating Potent In Vitro Activity of Delafloxacin Against Drug-Resistant Gonorrhea 7/16/2013
VBL Therapeutics Discloses Data About VB-201 Novel Mechanism and Pre-Clinical Efficacy in Atherosclerosis 7/8/2013
Cellectis Announces Groundbreaking in Vivo Proof of Concept Testing of Their Flagship UCART19 Product for Curative Therapy of Leukemia 7/8/2013
Pluristem Therapeutics (PSTI)'s Preclinical Results for Its PLX-RAD Cells Published in the Journal PLOS ONE 6/20/2013
TG Therapeutics, Inc. (MHA) Announces Presentation of Pre-Clinical Data on the Combination of TG-1101 and TGR-1202 at the International Conference on Malignant Lymphoma, Lugano, Switzerland 6/20/2013
Novartis AG (NVS) Ramps Up Alzheimer's Drug Pursuit as Rivals Fail 5/24/2013
Arsanis, Inc. Nominates Preclinical Candidate for Staphylococcus aureus Program 5/23/2013
H. Lundbeck A/S (LUN.CO) Release: Vortioxetine, a New Multimodal Agent in Development for the Treatment of Major Depression, Shows Effects on Cognitive Function in Several Preclinical Animal Models 5/22/2013
Merck & Co., Inc. (MRK), Bristol-Myers Squibb Company (BMY) and Roche (RHHBY)'s Human Immune-Boosting Cancer Drugs Seen Extending Lives 5/15/2013
Pluristem Therapeutics (PSTI) Release: Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia 5/13/2013
Starpharma Holdings Ltd's Dendrimer a Potential Viral Conjunctivitis Treatment 5/13/2013
Addex Therapeutics (ADXN.SW) Reports that Dipragluant Demonstrated Dose-Dependent mGlu5 Receptor Occupancy in a Non-Human Primate PET Study 5/1/2013
Evotec AG (EVTG.F): New Hormone to Treat Diabetes Published in "Cell" 4/26/2013
NicOx SA (COX.PA) Release: Pre-Clinical Results on Naproxcinod in Models of Muscular Dystrophy Presented at Muscular Dystrophy Association Scientific Conference 4/24/2013
Addex Therapeutics (ADXN.SW) Dipraglurant Normalizes Striatal Cholinergic Dysfunction in a Validated Preclinical Model of Primary Generalized Torsion Dystonia 1 (DYT1) 4/18/2013
Data on SEEK's Novel Immunotherapy for HIV Published in Virology Journal Antibody Treatment for HIV 4/16/2013
Innate Pharma (IPH.PA ) Presents New Data for Proprietary Programs Targeting TLR3 and KIR3DL2 4/12/2013
S-TARget Achieves In Vivo Proof of Concept for Its Allergy Vaccine SG100 4/8/2013
Spirogen Ltd. and Bioatla Present Positive Data on Next-Generation Warheads in ADCS Against Cancer 4/8/2013
Successful Vaccine Developments at Themis Bioscience, Pasteur Institute Technology Proves Its Effective Potential 3/27/2013
Proteome Sciences PLC (PRM.L): Developments in Alzheimer's Disease 3/18/2013
GENFIT Corp. (ALGFT) Release: TGFTX1 Program: Successful Identification of Proprietary ROR?t Ligands for the Treatment of Auto-Immune Diseases 3/13/2013
RegeneCure's Membrane Implant Shows 40% Accelerated Healing Time of Severe Bone Fractures in Pet Clinical Study 3/12/2013
PRANA Biotechnology (PRAN)'s PBT434 Inhibits Accumulation of Parkinson's Protein and Subsequent Death of Brain Cells 3/6/2013
Starpharma Holdings Ltd Release: Dendrimers Improve Anticancer Efficacy in Lung Metastasis Model 3/4/2013
BioLineRx Ltd.'s EDP-14, for Treatment of Severe and Persistent Asthma, to Enter the Company's Main Therapeutic Pipeline as BL-9010 2/28/2013
VIB: New Angle to Combat Malignant Brain Tumors in Children 2/28/2013
Roche (RHHBY) Research Sheds Light on Improving Neurological Deficits in Mouse Model of Down Syndrome 2/27/2013
Circassia Limited's Cat Allergy Treatment Shows Sustained Symptom Improvement 2/25/2013
Anergis Presents Preclinical Data of its Ragweed Allergy Vaccine Candidate AllerR 2/21/2013
Orion Corporation Release: Promising Preclinical and Phase I Data of a New Generation Androgen Receptor (AR) Inhibitor, ODM- 201, Presented at American Society of Clinical Oncology GU 2013 Symposium 2/15/2013
Mireven Announces Positive In-Vitro Results for miRNA-7-5p in Melanoma 2/12/2013
BioDiem Ltd. (BDM.AX) Progresses to Proof-of-Concept Testing of BDM-I Antimicrobial Effect Against Parasites 2/8/2013
BioDiem Ltd. (BDM.AX)'s Antimicrobial Tested as Treatment for TB, Fungal Infections, in National Institutes of Health (NIH) Research Program 2/1/2013
Addex Therapeutics (ADXN.SW) Dipraglurant Reduces Motor Abnormalities in a Preclinical Model Relevant for Several Rare Types of Dystonia 1/29/2013
Cellmid Records Positive Data in Midkine Antibody Study in Kidney Disease 1/24/2013
Open Monoclonal Technology and Recombinant Antibody Technology Announce OmniRa™ Scientific Publication 1/22/2013
BrainStorm Cell Therapeutics Inc. Establishes Safety of Repeat Doses of NurOwn in Mice; Pre-clinical Study Conducted at GLP-Compliant Harlan Laboratories, Inc. 1/10/2013
Addex Therapeutics (ADXN.SW) Announces Positive Data With ADX71441 in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease 1/7/2013
AMS Biotechnology (AMSBIO) Release: Integrating Extracellular Matrix Into 3D Spheroid Culture for a High Throughput Cell Invasion Assay 12/21/2012
AMS Biotechnology (AMSBIO) Researchers Respond Enthusiastically to Alvetex 3D Cell Culture 12/14/2012
BiondVax Pharmaceuticals' Universal Influenza Vaccine M-001 Significantly Enhances the Efficacy of the Human Pandemic H5N1 Bird Flu Vaccine 12/13/2012
Journal of Huntington's Disease Publishes Benefits of PRANA Biotechnology (PRAN)'s PBT2 12/13/2012
Adaptimmune Ltd. Announces Preliminary Results From an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma 12/13/2012
Adaptimmune Ltd. Announces Preliminary Results From an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma 12/11/2012
PRANA Biotechnology (PRAN) Release: Metal Hypothesis for Alzheimer's, Huntington and Other Neurodegenerative Diseases Declared Promising Therapeutic Strategy by Scientists at New York Academy of Sciences Symposium 12/5/2012
The Staby® Technology From Delphi Genetics Efficiently Applied to DNA-Vaccine 12/3/2012
AMSilk Release: Silicone Breast Implants With Spider Silk-Based Coating Show Reduced Side-Effects in Preclinical Studies 11/30/2012
Galapagos NV (GLPG.BR) Discovers Novel Class of Antibiotics 11/26/2012
Poor Sleep Can Lead to Schizophrenia Symptoms, University of Bristol Study 11/15/2012
"Calm Down" Genes Treat Epilepsy in Rats, University College London Study 11/13/2012
BioLineRx Ltd. Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 American Society of Hematology Annual Meeting 11/7/2012
Basilea Pharmaceutica (BSLN.SW)'s Novel Oncology Drug Candidate BAL101553: Data Presented at International Conference Demonstrate Dual Mode of Action 11/6/2012
Kamada Ltd. (KMDA.TA) Announces New Data on its Glassia Drug Supporting Its Diabetes Activities and Treatment of Additional Therapeutic Indications 11/6/2012
Compugen Ltd. (CGEN) Announces Discovery of Two Novel Immune Checkpoint Targets for Cancer Immunotherapy 10/31/2012
MiReven Announces Positive Preclinical Results for miR-7 in Head and Neck Cancer 10/25/2012
BioDiem Ltd. (BDM.AX) Reports Continued Progress in Development of Antimicrobial BDM-I 10/18/2012
Cytoo's 2D + Cell Culture Platform Reproduces in Vivo Conditions to Study Tumor Cell Motility 10/17/2012
Circassia Limited Announces Publication of ToleroMune® Cat Allergy Treatment Clinical Results in Journal of Allergy and Clinical Immunology 9/27/2012
Addex Therapeutics (ADXN.SW) mGluR4 Allosteric Modulator Effective in Multiple Sclerosis Model - a Novel Oral Small Molecule Approach for the Treatment of Multiple Sclerosis 9/24/2012
Ablynx and Its Partner Advance Nanobody Candidate ALX-0751 in Pre-Clinical Development 9/21/2012
Intellect Neurosciences, Inc. and Medical Research Council Technology Announce Humanization of Next-Generation Monoclonal Antibody to Amyloid Beta With Reduced Potential for Inflammation in the Brain of Alzheimer's Patients 9/19/2012
Compugen Ltd. (CGEN) Drug Candidate Demonstrates Attenuation of Autoimmunity and Reestablishment of Immune Balance 9/10/2012
MorphoSys AG and the University of Melbourne Publish Preclinical Data on the Role of GM-CSF in Inflammatory, Arthritic and Osteoarthritic Pain 9/10/2012
ValiRx Plc Release: VAL201 Update Regarding Breast Cancer Study 9/6/2012
PRANA Biotechnology (PRAN)'s Parkinson's Drug Meets The Michael J. Fox Foundation Development Milestone 8/29/2012
GenKyoTex S.A. s Lead NOX Inhibitor GKT137831 Demonstrates Activity in Models of Liver Fibrosis 8/8/2012
Fruit Flies Light the Way for A*STAR Scientists to Pinpoint Genetic Changes That Spell Cancer 7/30/2012
SuppreMol Begins Development of Anti-IL-3 Monoclonal Antibody to Diagnose and Treat Early Stage Rheumatoid Arthritis 7/27/2012
Rheumatoid Arthritis New Major Clinical Target After Mesoblast Limited Obtains Positive Results in Inflammatory Arthritis 7/24/2012
Addex Therapeutics (ADXN.SW) Announces the Publication of Positive Data on the Efficacy of mGluR4 Positive Allosteric Modulator in Parkinson's Disease Pre-Clinical Models 7/16/2012
Cancer Therapeutics Reveals Proof of Concept for Second Development Drug 7/5/2012
Pharming Group (PHGUF.PK): New Data Published on RUCONEST's Protective Effects After Severe Blood Loss 7/2/2012
Magnet Helps Target Transplanted Iron-Loaded Cells to Key Areas of Heart, INSERM Study 6/29/2012
Compugen Ltd. (CGEN) Announces Validation Results for a Second Potential Immune Checkpoint Target for Cancer Immunotherapy 6/27/2012
IDBS ELN Powers World Class Preclinical Research at the University of Cape Town 6/14/2012
Pantarhei Bioscience Study Findings Demonstrate the Disappearance of Breast Tumours During Treatment With the Human Fetal Estrogen Estetrol 6/6/2012
ValiRx Plc's Late Pre-clinical Study of VAL201 5/29/2012
PRECOS Launches Premium Bespoke Collection of Clinically Relevant Lung in Oncology Models for Drug Discovery 5/29/2012
Sichuan Agricultural University and LC Sciences Uncover the Epigenetics of Obesity 5/29/2012
Sanofi (France) (SAN.PA) to Test Cancer-starving Compound in China in 2013 5/25/2012
Sanofi (France) (SAN.PA) Pins Hope on Cancer-starving Compound 5/25/2012
ChinaBio(R) LLC Release: China Research Team Develops TB/HIV Combination Vaccine 5/24/2012
ProtAffin AG Releases New Preclinical Data for Lead Anti-inflammatory Product PA401 in Inflammatory Lung Disease 5/22/2012
Cardiac Function in Pre-Clinical Diabetic Diastolic Heart Failure Subjects Improved by Pluristem Therapeutics (PSTI)'s PLX Cells 5/15/2012
Bionor Pharma ASA Release: Successful Immunization and Safety Documented in Nasal Administration Study of the HIV Vaccine Vacc-4x Together With Endocine 5/10/2012
Immunocore Limited Release: Revolutionary New Cancer Targeting Technology Described in Nature Medicine 5/7/2012
Mucosis B.V. Announces Publication of Preclinical Data Demonstrating Superior Protection by Mucosally Administered Mimopath®-Based Influenza Vaccines 5/3/2012
Novo Nordisk A/S (NVO) Says Blood Drugs Could Hold Blockbuster Potential 5/2/2012
Compugen Ltd. (CGEN) Announces Initial Validation Results for Two Novel Immunomodulatory Proteins and Further Results for CGEN-15001 4/24/2012
Novartis AG (NVS) Compound Spurs Cartilage in Arthritic Mice 4/9/2012
Ablynx's Partner Shows That a Nanobody Can Elicit Superior Anti-Tumour Efficacy Compared to Conventional Monoclonal Antibody Approaches 4/4/2012
Basilea Pharmaceutica (BSLN.SW) Presents New Research Data on a Biomarker for Its Novel Oncology Drug Candidate BAL101553 at American Association for Cancer Research 4/4/2012
NOXXON Pharma AG's NOX-A12 Delays Glioblastoma Recurrence in Preclinical Model 4/4/2012
Successful Completion of Preclinical Development Studies in Summit Corporation's C. Difficile Program 4/4/2012
Kymab Announces Milestone in Kymouse™ Human Antibody Platform 4/2/2012
Scientists at Singapore Immunology Network, A*STAR, Discover Special Class of Natural Fats That Stimulates Immune Cells to Fight Diseases 4/2/2012
Immune Cells With a Killer Instinct: Tried-and-Tested Anti-Tumor Drug Displays New Effect, Medical University of Vienna Study 3/26/2012
Integrated DNA Technologies Oligos Used to Increase Efficiency of Detecting Genetic Variation 3/19/2012
BrainStorm Cell Therapeutics Inc. Expands Pipeline with the Initiation of a Study for Multiple Sclerosis 3/12/2012
Combination Therapy May Enhance Gemcitabine Activity for Pancreatic Cancer, University of Cambridge Study 2/28/2012
Allied Announces Coridon Pty Ltd to Develop HPV Therapeutic Vaccine 2/28/2012
Nature Release: BrainStorm Cell Therapeutics Inc.'s NurOwn™ Stem Cell Technology Offers Hope for Treating Huntington Disease 2/27/2012
PROLOR Biotech (PBTH) to Present Preclinical Data on Its Long-Acting Clotting Factors VIIa and IX at European Hemophilia Conference 2/23/2012
BioLineRx Ltd. Announces Publication of Pre-Clinical Results Demonstrating Efficacy of BL-7010, an Oral Treatment for Celiac Disease and Gluten Sensitivity 2/21/2012
TCG Lifesciences Announces Nomination of Pre-clinical Development Candidate 2/20/2012
PROLOR Biotech (PBTH) Announces Positive Preclinical Results from Comparative Study of its Long-Acting Clotting Factor VIIa 2/14/2012
Rabies Vaccines With Isconova's Matrix-M™ Adjuvant Launched in Russia 2/8/2012
GENFIT Corp. (ALGFT) Release: Conclusive Results of Regulatory Toxicology Studies With GFT505 2/8/2012
Pluristem Therapeutics (PSTI) to Expand Research & Development of Radiation Exposure Treatment 2/7/2012
Starpharma Holdings Ltd's Dendrimers Improve Efficacy of Docetaxel in Animals 2/1/2012
Ceptaris Therapeutics, Inc. Receives EMA Orphan Drug Designation for Proprietary Mechlorethamine Gel 1/18/2012
Institute of Translational Oncology (TRON) Release: First Preclinical Proof-of-Concept of Mutation-Based Individualized Cancer Vaccine 1/17/2012
GATC Biotech and LifeCodexx Complete Recruitment of Blood Samples for Clinical Study of Trisomy 21 Diagnostic Test 1/10/2012
Roche (RHHBY) and Itamar Medical Inc. Move Forward in Developing EndoPAT™ for Pre-Clinical Longitudinal Studies 1/4/2012
Galectin Therapeutics Presents Preclinical Data on the Treatment of Fatty Liver Disease and Fibrosis at EASL 12/16/2011
Fat-Burning Roche (RHHBY) Drug Stops Diabetes in Mice, Researchers Say 12/16/2011
Covagen Nominates Bispecific TNF/IL-17A Inhibitor as Drug Candidate to Enter Preclinical Development 12/12/2011
BioInvent - Anti-Cancer Activity of BI-505 Demonstrated in Animal Model 12/12/2011
NCSED Chooses Instem’s Integrated Software Suite for Preclinical Studies in China 12/8/2011
Addex Pharmaceuticals (ADXN.SW) Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors 11/28/2011
New Study Demonstrating the Selectivity of Progenra, Inc.'s Novel Anti-Tumor Compound 11/28/2011
A*STAR Singapore Scientists Lead Human Embryonic Stem Cell Study to Advance the Field of Regenerative Medicine Research 11/28/2011
Pantarhei Bioscience Announces Discovery of Antigen (ZP3) as a Treatment to Combat Ovarian Cancer 11/11/2011
Mesoblast Limited Reports Positive Results Using Intravenously Injected Adult Stem Cells for Type 2 Diabetes 11/10/2011
Telormedix Announces Promising TMX-202 Preclinical Results for Skin Cancer Treatment 10/31/2011
BerGenBio AS Initiates Preclinical Development of Novel AXL Inhibitor BGB324 10/31/2011
Treatment with Teva Pharmaceutical Industries Limited (TEVA)'s COPAXONE(R) in Multiple Sclerosis Demonstrated Remyelination and Neuroprotective Effects in a Preclinical Setting 10/20/2011
ProtAffin AG Announces Preclinical Data in Multiple Sclerosis for MCP-1 Decoy Program 10/20/2011
Medicilon-MPI Preclinical Research (Shanghai) LLC to Complete Pre-Clinical Work on South Korean Anti-Depressant 10/20/2011
Arteria Will Carry Out Regulatory Preclinical Studies in the Field of Postprandial Hypertriglyceridemia Following Excellent Initial Results 10/19/2011
Pulmonary Fibrosis Foundation to Fund Further Therapeutic Evaluation Studies for Compugen Ltd. (CGEN)-Discovered Drug Candidate 10/12/2011
A*STAR Scientists Uncover Critical Link between Inflammation and Cancer 9/28/2011
Patrys Limited (PATZF.PK)'s Lead Product PAT-SM6 Shows Promise in Multiple Myeloma 9/26/2011
Laurantis Pharma Oy Release: New Treatment for Lymphedema Could Mean Breakthrough for Breast Cancer Patients 9/22/2011
NicOx SA (COX.PA) Presents New Preclinical Data for NCX 6560 9/19/2011
PROLOR Biotech (PBTH) Announces Positive Preclinical Results From Comparative Study of its Long-Acting Clotting Factor VIIa 9/15/2011
Roche (RHHBY)'s xCELLigence System Monitors Beating Periodicity of Stem Cell Derived Cardiomyocytes in Preclinical Safety Assessment 9/15/2011
Compugen Ltd. (CGEN) Announces Validation of Two Immune System Modulating Drug Candidates 9/13/2011
GENFIT Corp. (ALGFT): New Data Support the Efficacy of Gft505 for the Treatment of NAFLD/NASH 9/12/2011
A*STAR Landmark Discovery Paves the Way for More Targeted Cancer Treatment & Offers Hope for Cancer Prevention 9/8/2011
BioLineRx Ltd. In-Licenses BL-7050, a Novel, Orally-Available Molecule for the Treatment of Neuropathic and Inflammatory Pain 9/7/2011
Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) Cancer Drug Demonstrates 100% Oral Bioavailability in New Study 9/6/2011
Patrys Limited (PATZF.PK) Anti-Cancer Product Shows Promise in Multiple Myeloma 8/17/2011
Hiru Corporation (HIRU)'s MindUp BioResearch Research Team Published Their New Results on the Topic of Overcoming Multiple-Drug Resistance in Lung Cancer Therapy 8/5/2011
Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Announce New Preclinical Study Results Showing MDV3100 Blocks Breast Cancer Cell Growth 8/4/2011
Beijing Genomics Institute (BGI) and GT Life Sciences Sequence Chinese Hamster Ovary Genome 8/2/2011
Humabs Discovers the First Antibody to Neutralize both Group 1 and Group 2 Influenza A Viruses 7/28/2011
Genethon and Children's Hospital Boston Get FDA Approval for a Wiskott Aldrich Gene Therapy Trial 7/21/2011
Functional Cure in Non-Human Primates Achieved With Simian Version of VIRxSYS Corporation' HIV Vaccine VRX1273 7/18/2011